Literature DB >> 1328280

Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients.

R S Buller1, T C Bailey, N A Ettinger, M Keener, T Langlois, J P Miller, G A Storch.   

Abstract

A quantitative modification of the shell vial assay was used to investigate cytomegalovirus viremia in solid-organ transplant recipients. The level of viremia detected in 109 of 407 specimens ranged from 0.02 to 28 infectious foci per 100,000 leukocytes. By using a Poisson model, a technique was developed to determine 95% confidence limits for the measured levels of viremia. These confidence limits were used to determine the level of viremia that could be excluded by culturing a given number of cells. Longitudinal assessment of two transplant recipients revealed different patterns of viremia and demonstrated that significant disease sometimes occurred with low-level viremia. On the basis of the results of the studies, culture of at least 4 x 10(6) leukocytes is recommended for the sensitive detection of cytomegalovirus viremia.

Entities:  

Mesh:

Year:  1992        PMID: 1328280      PMCID: PMC270488          DOI: 10.1128/jcm.30.10.2620-2624.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen.

Authors:  C A Gleaves; T F Smith; E A Shuster; G R Pearson
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

3.  Prolonged human cytomegalovirus viremia following bone marrow transplantation.

Authors:  J A Zaia; S J Forman; M T Gallagher; E Vanderwal-Urbina; K G Blume
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

4.  Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection.

Authors:  G Gerna; M Parea; E Percivalle; D Zipeto; E Silini; G Barbarini; G Milanesi
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

Review 5.  Impact of cytomegalovirus infection on organ transplant recipients.

Authors:  R H Rubin
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

6.  Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients.

Authors:  L Marsano; R P Perrillo; M W Flye; D W Hanto; E D Spitzer; J R Thomas; P R Murray; D W Windus; E M Brunt; G A Storch
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

7.  Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia.

Authors:  J D Meyers; P Ljungman; L D Fisher
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

8.  Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections.

Authors:  S H Cheeseman; R H Rubin; J A Stewart; N E Tolkoff-Rubin; A B Cosimi; K Cantell; J Gilbert; S Winkle; J T Herrin; P H Black; P S Russell; M S Hirsch
Journal:  N Engl J Med       Date:  1979-06-14       Impact factor: 91.245

9.  Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia.

Authors:  G Gerna; D Zipeto; M Parea; M G Revello; E Silini; E Percivalle; M Zavattoni; P Grossi; G Milanesi
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

10.  Glomerulopathy associated with cytomegalovirus viremia in renal allografts.

Authors:  W P Richardson; R B Colvin; S H Cheeseman; N E Tolkoff-Rubin; J T Herrin; A B Cosimi; A B Collins; M S Hirsch; R T McCluskey; P S Russell; R H Rubin
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

View more
  13 in total

1.  Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells.

Authors:  R Rodríguez Roche; M Alvarez; M G Guzmán; L Morier; G Kourí
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 2.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay.

Authors:  N Veal; C Payan; D Fray; L Sarol; O Blanchet; S Kouyoumdjian; F Lunel
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

4.  Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR.

Authors:  T C Roberts; R S Buller; M Gaudreault-Keener; K E Sternhell; K Garlock; G G Singer; D C Brennan; G A Storch
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Determination of the number of blood samples needed for optimal detection of cytomegalovirus viremia in immunocompromised patients using a shell-vial assay.

Authors:  J Reina; I Blanco; M Munar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

6.  Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions.

Authors:  A Erice; M A Holm; M V Sanjuan; D L Dunn; P C Gill; H H Balfour
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 7.  Physical and chemical methods for enhancing rapid detection of viruses and other agents.

Authors:  J H Hughes
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

8.  Comparison of heparin and EDTA transport tubes for detection of cytomegalovirus in leukocytes by shell vial assay, pp65 antigenemia assay, and PCR.

Authors:  G A Storch; M Gaudreault-Keener; P C Welby
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

9.  Comparison of cytomegalovirus antigenemia assay with shell vial-indirect immunofluorescence assay for rapid detection of cytomegalovirus in blood.

Authors:  S M Lipson; Z Ciamician; M H Kaplan
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

10.  Neonatal cytomegalovirus infection: diagnostic modalities available for early disease detection.

Authors:  Prateek Bhatia; A Narang; Ranjana W Minz
Journal:  Indian J Pediatr       Date:  2010-01       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.